Annaosanchun (YC-6) is primarily utilized in research and development within the pharmaceutical industry, particularly in the study of neurological disorders. It has shown potential as a therapeutic agent for conditions such as Alzheimer's disease due to its ability to modulate specific pathways in the brain. Additionally, it is being investigated for its neuroprotective properties, which could help in mitigating damage caused by neurodegenerative processes. Researchers are also exploring its use in enhancing cognitive functions and memory retention, making it a promising candidate for future treatments in mental health and cognitive decline.